Search

Interstitial lung diseases (ILDs) other than idiopathic pulmonary fibrosis (IPF) have an array of immunomodulatory treatment options compared with IPF, due to their inflammatory component. However, there is a relative paucity of guidance on the management of this heterogeneous group of diseases. In ILDs other than IPF, immunosuppression is the cornerstone of therapy, with varying levels of evidence for different immunomodulatory agents and for each specific ILD. Classification of ILDs is important for guiding treatment decisions. Immunomodulatory agents mainly include corticosteroids, mycophenolate mofetil (MMF), azathioprine, methotrexate, cyclophosphamide and rituximab. In this review, the available evidence for single agents in the most common ILDs is first discussed. We then reviewed practical therapeutic approaches in connective tissue disease–related ILD and interstitial pneumonia with autoimmune features, scleroderma-related ILD, vasculitis and dermatomyositis with hypoxemic respiratory failure, idiopathic non-specific interstitial pneumonia, hypersensitivity pneumonitis sarcoidosis, fibrosing organizing pneumonia and eosinophilic pneumonia. The treatment of acute exacerbations of ILD is also discussed. Therapy augmentation in ILD is dictated by the recognition of progression of disease. Criteria for the evaluation of progression of disease are then discussed. Finally, specific protocol and measures to increase patients' safety are reviewed as well, including general monitoring and serologic surveillance, Pneumocystis jirovecii prophylaxis, patients' education, genetic testing for azathioprine, MMF serum levels and cyclophosphamide administration protocols. Immunomodulatory therapies are largely successful in the management of ILDs and can be safely managed with the application of specific protocols, precautions and monitoring. [ABSTRACT FROM AUTHOR]

Key message: We summarise modelling studies of the most economically important cassava diseases and arthropods, highlighting research gaps where modelling can contribute to the better management of these in the areas of surveillance, control, and host-pest dynamics understanding the effects of climate change and future challenges in modelling. For over 30 years, experimental and theoretical studies have sought to better understand the epidemiology of cassava diseases and arthropods that affect production and lead to considerable yield loss, to detect and control them more effectively. In this review, we consider the contribution of modelling studies to that understanding. We summarise studies of the most economically important cassava pests, including cassava mosaic disease, cassava brown streak disease, the cassava mealybug, and the cassava green mite. We focus on conceptual models of system dynamics rather than statistical methods. Through our analysis we identified areas where modelling has contributed and areas where modelling can improve and further contribute. Firstly, we identify research challenges in the modelling developed for the surveillance, detection and control of cassava pests, and propose approaches to overcome these. We then look at the contributions that modelling has accomplished in the understanding of the interaction and dynamics of cassava and its' pests, highlighting success stories and areas where improvement is needed. Thirdly, we look at the possibility that novel modelling applications can achieve to provide insights into the impacts and uncertainties of climate change. Finally, we identify research gaps, challenges, and opportunities where modelling can develop and contribute for the management of cassava pests, highlighting the recent advances in understanding molecular mechanisms of plant defence. [ABSTRACT FROM AUTHOR]

The article reviews the book "Management Consulting: Emergence and Dynamics of a Knowledge Industry," edited by Matthias Kipping and Lars Engwall.

The article reviews several books, including "Worlds of Power: Religious Thought and Political Practice in Africa," by Stephen Ellis and Gerrie ter Haar, "The New Faces of Christianity: Believing the Bible in the Global South," by Philip Jenkins, and "An Introduction to Pentecostalism: Global Charismatic Christianity," by Allan Anderson.

The article reviews the book "Talking Over the Years: A Handbook of Dynamic Psychotherapy With Older Adults," edited by Sandra Evans and Jane Garner.

Reviews the book "On B®and," by Wally Olins.

Reviews the book `Community Child Health and Paediatrics,' by David Harvey and Marion Miles.

The article reviews the book "Opting out of War: Strategies to Prevent Violent Conflict" by Mary B. Anderson and Marshall Wallace.

The article reviews the book "SIPRI Yearbook 2012."

The article reviews the book "Intercultural Theology: Approaches and Themes," edited by Mark J. Cartledge and David Cheetham.

The article reviews the book "The Great Emergence: How Christianity is Changing and Why," by Phyllis Tickle.

Reviews the book 'DSM-IV-TR in Action,' by Sophia F. Dziegielewski.